SCOR in Targeted Therapies for Infant Leukemias Project 4: MicroRNA Sequencing of Infant AML
N/A
1 Year
Both
Leukemia
Trial Information
SCOR in Targeted Therapies for Infant Leukemias Project 4: MicroRNA Sequencing of Infant AML
OBJECTIVES:
- Sequence the microRNAs present in 20 infant AML samples as a pilot study.
- Compare microRNAs present in infant AML samples to infant ALL samples that are being
concurrently sequenced in a separate study to identify lineage- and
translocation-specific microRNAs.
OUTLINE: This is a multicenter study.
Previously collected cryopreserved cells from diagnosis are sequenced using reverse
transcriptase-PCR.
Inclusion Criteria
DISEASE CHARACTERISTICS:
- Diagnosis of acute myeloid leukemia
- Available cryopreserved cells from diagnosis
PATIENT CHARACTERISTICS:
- Not specified
PRIOR CONCURRENT THERAPY:
- Not specified
Type of Study:
Observational
Study Design:
N/A
Outcome Measure:
Sequence of the microRNAs present in 20 infant acute myeloid leukemia (AML) samples
Safety Issue:
No
Principal Investigator
Michael Cleary, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Stanford University
Authority:
United States: Federal Government
Study ID:
CDR0000687628
NCT ID:
NCT01229124
Start Date:
October 2010
Completion Date:
Related Keywords:
- Leukemia
- childhood acute myeloid leukemia/other myeloid malignancies
- Leukemia
- Leukemia, Myeloid, Acute
- Leukemia, Myeloid
Name | Location |
|---|
